This trial is registered with the Dutch trial registry that has been offline for over a year and hasn’t been registered in any other database. We will update this record once it becomes available. All data are estimates.
Topic Healthy Subjects
Compound Psilocybin
2C-X
Country Netherlands
Visit trial
Status
Completed
Results Published
Yes
Start date
01 January 2022
End date
01 January 2023
Chance of happening
100%
Phase
Not Applicable
Design
Open
Type
Interventional
Generation
First
Participants
22
Sex
All
Age
18- 65
Therapy
No
Trial Details
This trial is registered with the Dutch trial registry that has been offline for over a year and hasn't been registered in any other database. We will update this record once it becomes available.NCT Number NL8813
Sponsors & Collaborators
Maastricht UniversityMaastricht University is host to the psychopharmacology department (Psychopharmacology in Maastricht) where various researchers are investigating the effects of psychedelics.
Papers
Assessment of the acute effects of 2C-B vs psilocybin on subjective experience, mood and cognitionThis double-blind study (n=22) compares the effect of 2C-B (20mg) and psilocybin (15mg). It finds that 2C-B elicited alterations in consciousness of a psychedelic nature but with a shorter duration of self-reported effects than psilocybin. The study categorised 2C-B (at least at that dose) as a subjectively "lighter" psychedelic.